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This study aims to evaluate the efficacy of repeated external ± internal EC
in such patients. In case of persistent AF after a first external EC, a repeated
external EC was performed. After the inefficiency of 2 external EC, internal
cardioversion was perfomed.
Methods: Patients with persistent AF, after inefficient external EC and oral
pretreatment with amiodarone were included. After a mean of 3 months,
repeated external ± internal EC was proposed in order to recover sinus rhythm
(SR). These patients were compared with a control group, sex and age
matched, also treated with amiodarone but in whom the external EC was suc-
cessful at the first attempt.
The 2 groups were analyzed in a case-control study. We analyzed the rate
of successful external EC after the 2 procedures in the AF group. The recur-
rence rate of AF was analyzed after one year in both groups. 
Results: Twenty patients got unsuccessful external EC (mean age=64.1 years).
There were 40 patients in the control group (mean age=67.1 years). External EC
was repeated after a mean of 3.5±5.4 months. No patient needed internal EC.
After one year, there was no difference in the recurrence rate of AF in both groups
(35% vs. 27%; p=0.244, in studied and control groups, respectively).
Conclusion: Repeated external EC allows SR recovery in all the patients
with AF under long term oral amiodarone, after a first unsuccessful external
EC. The AF recurrence rate after one year was similar to patients in whom the
first attempt was successful at once. 
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Aim: of the study was to evaluate the possible existence of a nightmare
modulation of VTCL stability in ICD recipients.
Method: We evaluated 45 ICD pts with 104VT episodes occurred both at
day (80) and night (24) time in a FU period of 5±3years. As index of VTCL
stability we considered the coefficient of variance (CVRR=SD/Mean RRX100)
of the last 5-10 consecutive stored normal RR intervals prior to the VT.
Results: During day-night, the VTCL was 340±29ms and 352±45ms
(p=NS) and the CVRR was 2,83±0,52 and 3,36±0,68(p=0.017).
Conclusions: The VTCL is less stable during night compared to the day
time, in pts with DCM. A possible explanation is that, the sympathovagal
nightmare alteration modifies the electrophysiological properties of the
arrhythmogenic substrate. The clinical significance of this study is towards
programming the ICD parameters. 
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Introduction: Very narrow QRS has been described whose prevalence and
prognosis relevance in the normal population is unknown. 
Methods: 546 healthy men between 50 and 60 yo (group 1) and 373 similar
patients with coronary artery disease (368 men, EF < 50% in 40%) (group 2)
underwent signal averaged ECG allowing precise measurement of QRS dura-
tion. All cause mortality was determined after 17±3 years follow-up.
Results: Mean QRS duration was 97±13ms for group 1 and 103±16ms for
group 2. 85 group 1 subjects (16%) had QRS < 85ms and 23 (4%) had QRS
>120ms. 44 group 2 patients (12%) had QRS < 85ms and 44 (12%) had QRS
>120ms. QRS were larger in case of lower EF, lack of previous angioplasty
and multivessel disease. 
All cause mortality in group 1 was 10,4% (57/546): 6/85 in case of QRS
<85ms (7%) and 2/23 (9%) in case of QRS > 120ms (p=ns compared to
normal QRS duration). HR for all-cause mortality in case of QRS < 85ms was
0,75 (95% CI 0.32-1.76, p = 0,52) and 0,86 (95% CI 0.21-3.53, p = 0,84) for
QRS >120ms.
All cause mortality in group 2 was 29% (109/373): 7/44 in case of QRS
<85ms (16%) and 22/44 (50%) in case of QRS > 120ms (p=0.002 when com-
pared to normal QRS duration). Adjusted HR for all-cause mortality in case
of QRS < 85ms was 0,65 (95% CI 0.29-1.45, p = 0,29) and 1.73 (95% CI
1.02-2.94, p = 0,05) for QRS > 120ms. 
Late potentials (LP) were present in SA-ECG in 116 group 1 subjects
(21%). LP were present in 100 group 2 patients (27%) and were significantly
related to multivessel disease, altered EF, lack of revascularization or of
angioplasty. LP were more frequently observed in case of QRS > 120ms in
both groups. LP were nor related to all-cause mortality in both groups.
Conclusion: QRS “narrower than normal” (< 85ms) can be observed in a
significant porpotion of healthy males between 50 and 60 years old and in
similar patients with ischemic heart disease. In opposition to QRS > 120 msec
which are independantly related to a higher all-cause mortality in coronary
artery disease patients, QRS <85ms were not linked to prognosis in any group.
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Background: Following the exponential growth of cardiac device implanta-
tion, there is an increase of lead extraction indications. In the meantime, the tools,
the indications, and the outcomes of those procedures continue to progress.
Objectives: The purpose of this study was to examine contemporary indi-
cations, outcomes, and complications of transvenousleadextraction in a large
series of patients at a high-volume lead extraction center.
Methods: We performed a retrospective cohort study of consecutive
patients undergoing leadextraction at a single, high-volume center.Our extrac-
tion strategy consists in manual traction, locking stylet traction, laser use fol-
lowed by inferior approach in case of failure.
Patient and lead characteristics and the indications, outcomes, and need for
laser assistance were analyzed
Results: From January 2002 to December 2013, a total of 751 chronic
endovascular leads were removed from 391patients.The mean age was years
68 (range 13- 98). Seventy-five percent of patients were males. Median
implantation duration was 5,5 years. Indications for extraction were systemic
infection (33,3%), pocket infection (25,1%), mechanical lead failure (32,7%),
and upgrade of device system (6,1%)due to thrombosis of veinous access.
Extraction was successful in 97,7% of patients with complete removal.
Laser assistance for extraction wasrecquired in 259 patients (66,2%),
completed with an inferior approach in 38 patients(9,7%). Complications were
death in 2 patients (0,5%),bleeding in 21 patients (5,4%), pericardial tam-
ponade in 8 patients (2%).
In univariate analysis, laser-assisted lead extraction was required more fre-
quently for leads that were implanted more 36 months than others (p<0,001),
as well as for passive leads compared to active leads (p=0,04).
Conclusion: Lead extraction can be safely and succefully performed in the
majority of patients, with limited life-threatening complications.
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Introduction: More and more frequently, silent atrial fibrillation (AF)
events are detected in intracardiac electronic device (ICED) memory (“infra-
